๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients

โœ Scribed by L. Murri; A. Ludice

Book ID
114784428
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
247 KB
Volume
92
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy and safety evaluation of lorecl
Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients
โœ T Rentmeester; J Hulsman ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 381 KB

Thirteen drug-resistant epilepsy patients received loreclezole as add-on therapy. The trial lasted 6 months. Loreclezole was dosed to reach a target plasma concentration between 1 and 3 mg/l. The seizure frequency in the total group decreased by 23%. A reduction of 50% or more was observed in four p